Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension

INTRODUCTION: Pulmonary arterial hypertension (PAH) is a rare, incurable disease associated with decreased life expectancy and a marked impact on quality of life (QoL). There are three classes of drugs available for treatment: endothelin receptor antagonists (ERA), drugs acting on nitric oxide pathw...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Evan W, Llewellyn, Samuel, Beaudet, Amélie, Kosmas, Charlotte E, Gin-Sing, Wendy, Doll, Helen A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016589/
https://www.ncbi.nlm.nih.gov/pubmed/29950821
http://dx.doi.org/10.2147/PPA.S160662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016589/
https://www.ncbi.nlm.nih.gov/pubmed/29950821
http://dx.doi.org/10.2147/PPA.S160662

Ejemplares similares